DWDing Wang

Ding Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ding Wang has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ATHENA: Atherosclerosis through Hierarchical Explainable Neural Network Analysis

    by Irsyad Adam, Steven Swee, Erika Yilin Zheng, Ethan Ji, William Speier, Ding Wang, Alex Bui, Wei Wang, Karol Watson, Peipei Ping

  • Open Access

    Data-Driven Insights into the Association Between Oxidative Stress and Calcium-Regulating Proteins in Cardiovascular Disease

    by Namuna Panday, Dibakar Sigdel, Irsyad Adam, Joseph Ramirez, Aarushi Verma, Anirudh N. Eranki, Wei Wang, Ding Wang, Peipei Ping

    A growing body of biomedical literature suggests a bidirectional regulatory relationship between cardiac calcium (Ca2+)-regulating proteins and reactive oxygen species (ROS) that is integral to the pathogenesis of various cardiac disorders via oxidative stress (OS) signaling. To address the challenge of finding hidden connections within the growing volume of biomedical research, we developed a data science pipeline for efficient data extraction, transformation, and loading. Employing the CaseOLAP (Context-Aware Semantic Analytic Processing) algorithm, our pipeline quantifies interactions between 128 human cardiomyocyte Ca2+-regulating proteins and eight cardiovascular disease (CVD) categories. Our machine-learning analysis of CaseOLAP scores reveals that the molecular interfaces of Ca2+-regulating proteins uniquely associate with cardiac arrhythmias and diseases of the cardiac conduction system, distinguishing them from other CVDs. Additionally, a knowledge graph analysis identified 59 of the 128 Ca2+-regulating proteins as involved in OS-related cardiac diseases, with cardiomyopathy emerging as the predominant category. By leveraging a link prediction algorithm, our research illuminates the interactions between Ca2+-regulating proteins, OS, and CVDs. The insights gained from our study provide a deeper understanding of the molecular interplay between cardiac ROS and Ca2+-regulating proteins in the context of CVDs. Such an understanding is essential for the innovation and development of targeted therapeutic strategies.


  • Open Access

    Data-driven insights into the association between oxidative stress and calcium-regulating proteins in cardiovascular disease

    by Namuna Panday, Dibakar Sigdel, Irsyad Adam, Joseph Ramirez, Aarushi Verma, Anirudh Eranki, Wei Wang, Ding Wang, Peipei Ping

    A growing body of biomedical literature suggests a bidirectional regulatory relationship between cardiac calcium (Ca 2+ )-regulating proteins and reactive oxygen species (ROS), which is integral to the pathogenesis of various cardiac disorders via oxidative stress signaling. To address the challenge of finding hidden connections within the growing volume of biomedical research, we developed a data science pipeline for efficient data extraction, transformation, and loading. Employing the CaseOLAP (Context-Aware Semantic Analytic Processing) algorithm, our pipeline quantifies interactions between 128 human cardiomyocyte Ca 2+ -regulating proteins and eight cardiovascular disease (CVD) categories. Our machine learning analysis of CaseOLAP scores reveals that the molecular interfaces of Ca 2+ -regulating proteins uniquely associate with cardiac arrhythmias and diseases of the cardiac conduction system, distinguishing them from other CVDs. Additionally, a knowledge graph analysis identified 59 of the 128 Ca 2+ -regulating proteins as involved in OS-related cardiac diseases, with cardiomyopathy emerging as the predominant category. By leveraging a link prediction algorithm, our research illuminates interactions between Ca 2+ -regulating proteins, OS, and CVDs. The insights gained from our study provide a deeper understanding of the molecular interplay between cardiac ROS and Ca 2+ -regulating proteins in the context of CVDs. Such understanding is essential for the innovation and development of targeted therapeutic strategies.

  • Open Access

    Building an Ethical and Trustworthy Biomedical AI Ecosystem for the Translational and Clinical Integration of Foundation Models

    by Baradwaj Simha Sankar, Destiny Gilliland, Jack Rincon, Henning Hermjakob, Yu Yan, Irsyad Adam, Gwyneth Lemaster, Dean Wang, Karol Watson, Alex Bui, et al.

    Foundation Models (FMs) are gaining increasing attention in the biomedical artificial intelligence (AI) ecosystem due to their ability to represent and contextualize multimodal biomedical data. These capabilities make FMs a valuable tool for a variety of tasks, including biomedical reasoning, hypothesis generation, and interpreting complex imaging data. In this review paper, we address the unique challenges associated with establishing an ethical and trustworthy biomedical AI ecosystem, with a particular focus on the development of FMs and their downstream applications. We explore strategies that can be implemented throughout the biomedical AI pipeline to effectively tackle these challenges, ensuring that these FMs are translated responsibly into clinical and translational settings. Additionally, we emphasize the importance of key stewardship and co-design principles that not only ensure robust regulation but also guarantee that the interests of all stakeholders—especially those involved in or affected by these clinical and translational applications—are adequately represented. We aim to empower the biomedical AI community to harness these models responsibly and effectively. As we navigate this exciting frontier, our collective commitment to ethical stewardship, co-design, and responsible translation will be instrumental in ensuring that the evolution of FMs truly enhances patient care and medical decision-making, ultimately leading to a more equitable and trustworthy biomedical AI ecosystem.


  • Open Access

    Heterogeneity of proteome dynamics between connective tissue phases of adult tendon

    by Deborah Simpson, Howard Choi, Ding Wang, Mark Prescott, Andrew A. Pitsillides, Jayesh Dudhia, Peter D. Clegg, Peipei Ping, Chavaunne T. Thorpe

    Maintenance of connective tissue integrity is fundamental to sustain function, requiring protein turnover to repair damaged tissue. However, connective tissue proteome dynamics remain largely undefined, as do differences in turnover rates of individual proteins in the collagen and glycoprotein phases of connective tissue extracellular matrix (ECM). Here, we investigate proteome dynamics in the collagen and glycoprotein phases of connective tissues by exploiting the spatially distinct fascicular (collagen-rich) and interfascicular (glycoprotein-rich) ECM phases of tendon. Using isotope labelling, mass spectrometry and bioinformatics, we calculate turnover rates of individual proteins within rat Achilles tendon and its ECM phases. Our results demonstrate complex proteome dynamics in tendon, with ~1000-fold differences in protein turnover rates, and overall faster protein turnover within the glycoprotein-rich interfascicular matrix compared to the collagen-rich fascicular matrix. These data provide insights into the complexity of proteome dynamics in tendon, likely required to maintain tissue homeostasis.

  • Open Access

    Cardiovascular proteomics in the era of big data: experimental and computational advances

    by Maggie P. Y. Lam, Edward Lau, Dominic C. M. Ng, Ding Wang, Peipei Ping

    Proteomics plays an increasingly important role in our quest to understand cardiovascular biology. Fueled by analytical and computational advances in the past decade, proteomics applications can now go beyond merely inventorying protein species, and address sophisticated questions on cardiac physiology. The advent of massive mass spectrometry datasets has in turn led to increasing intersection between proteomics and big data science. Here we review new frontiers in technological developments and their applications to cardiovascular medicine. The impact of big data science on cardiovascular proteomics investigations and translation to medicine is highlighted.


  • Open Access

    A large dataset of protein dynamics in the mammalian heart proteome

    by Edward Lau, Quan Cao, Dominic C.M. Ng, Brian J. Bleakley, T. Umut Dincer, Brian M. Bot, Ding Wang, David A. Liem, Maggie P.Y. Lam, Junbo Ge, et al.

    Protein stability is a major regulatory principle of protein function and cellular homeostasis. Despite limited understanding on mechanisms, disruption of protein turnover is widely implicated in diverse pathologies from heart failure to neurodegenerations. Information on global protein dynamics therefore has the potential to expand the depth and scope of disease phenotyping and therapeutic strategies. Using an integrated platform of metabolic labeling, high-resolution mass spectrometry and computational analysis, we report here a comprehensive dataset of the in vivo half-life of 3,228 and the expression of 8,064 cardiac proteins, quantified under healthy and hypertrophic conditions across six mouse genetic strains commonly employed in biomedical research. We anticipate these data will aid in understanding key mitochondrial and metabolic pathways in heart diseases, and further serve as a reference for methodology development in dynamics studies in multiple organ systems.


  • Prioritizing Proteomics Assay Development for Clinical Translation

    by Maggie P.Y. Lam, Vidya Venkatraman, Quan Cao, Ding Wang, T. Umut Dincer, Edward Lau, Andrew I. Su, Yi Xing, Junbo Ge, Peipei Ping, et al.